10:45am ET
Investing
The 7 Most Heavily Shorted NYSE Stocks
Only one of the seven stocks traded on the New York Stock Exchange with the largest number of shares held short as of October 15 experienced a decline in short interest.
ABBV Coverage Page 45
8:35am ET
Investing
UBS’s Big List of Quality Stocks to Buy Now
UBS polled all of its analysts, who came up with 26 stocks by now. Here are the ones that offer large cap growth with the best upside.
7:20am ET
Investing
Sprint Drops From the 5 Most Shorted NYSE Stocks
The most shorted stocks on the New York Stock Exchange at the September 30 settlement dates saw rising short interest during the two-week period.
7:55am ET
Investing
AbbVie Joins the 5 Most Shorted NYSE Stocks
Short sellers shied away from Bank of American enough that it slipped out of the top five most shorted stocks on the New York Stock Exchange.
1:30pm ET
Investing
Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late.
10:55am ET
Health and Healthcare
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
A new research report from UBS focuses on four top companies that are making great strides in treatments for patients -- and generating gigantic revenues.
7:35am ET
Investing
Sprint Joins the 5 Most Shorted NYSE Stocks
Surges in short interest between the August 15 and August 29 settlement dates pushed Sprint into the top five most shorted stocks on the New York Stock Exchange.
2:10pm ET
Health and Healthcare
Is Infinity Fully Valued Now, or Is More Upside Left?
Infinity Pharmaceuticals will partner with Abbvie to further develop and commercialize IPI-145, also known as Duvelisib.
Jon C. Ogg 10:45am ET
Health and Healthcare
Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014
A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of 2014
8:40am ET
Health and Healthcare
AbbVie Earnings Take Back Seat to Shire Merger
AbbVie reported better-than-expected second-quarter 2014 results before markets opened Friday morning, due in part to strong sales of its Humira anti-inflammatory drug.
Paul Ausick 8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include Alcatel-Lucent, Apple, FireEye, JDSU Uniphase and solar stocks.
8:55am ET
Health and Healthcare
Analyst Cancer and Biotech Stock Picks From ASCO
ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest health care…
8:20am ET
Health and Healthcare
Why You Buy Big Pharma If the Market Crashes
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is large cap pharmaceuticals. Here are their top large cap pharmaceuticals to buy…
8:25am ET
Investing
Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, May 7, 2014. They include eBay, GNC, Groupon, Hecla Mining, J.C. Penney and Whole Foods.
11:20am ET
Retail
Why Target Shares Fell Rather Than Rose on CEO Firing
Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim CEO and chairman do not seem like serious candidates for the job.